Thomas Gallup

[Thomas Gallup @tdgallup]

@KristinHuntoon @BettyKimLab @wenjiang_nano @DYLee_BME woohoo westerns!!

[Kristin Huntoon @KristinHuntoon]

It is that time of year - summer thus summer students! Eager to learn how to #endcancer & all the techniques to gather the data. #teamscience @BettyKimLab @wenjiang_nano @tdgallup @MDAndersonNews

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Thrilling #comeback. We are down 48-52. We need your help to push us to the finish line. Ten hours left to vote #matchup6 #STATMadness. Keep us fighting for⁦ another round ⁦@MDAndersonNews⁩ #endcancer ⁦@NatureNano⁩ ⁦ https://t.co/xP6KpmwStC

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

We made it to the final 16 (Round 3) because of your votes #StatMadness. We are #Matchup 6. Please vote today and everyday for the day 5 days. Let’s get our ⁦@MDAndersonNews⁩ team to the finals! https://t.co/xP6KpmwStC

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Requesting all supporters of ⁦@MDAndersonNews⁩ to cast your votes for: https://t.co/VOmdoncV5V @BettyKimLab @wenjiang_nano @HenryKuerer @STATNews #EndCancer Matchup 7 and 12. #KeepUsInTheGame https://t.co/xP6Kpmxqja

[Thomas Gallup @tdgallup]

@wenjiang_nano @BettyKimLab @ACKoongMDPhD @JingLi_MD_PhD @MDAndersonNews congratulations!!

[UT MD Anderson @UTMDAnderson]

Meet our Dr. Betty Kim. Born in South Korea and raised in Canada, find out how she made her way to Houston, where she leads a cutting-edge research team at MD Anderson. https://t.co/dzhL851ePy @BettyKimLab #Research #EndCancer

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Excited to share our study @natBME https://t.co/KbeVZkmbOu The next demystifying anti-#aging, technology for younger-looking skin and beyond? #proteinloss #exosome #antiwrinkle @oncsurgery @MDAndersonNews @wenjiang_nano Andrew Lee @DaeYongLee5 @YWangPhD @KristinHuntoon @tdgallup

[Kristin Huntoon @KristinHuntoon]

Stop ✋️the publication of anatomy texts discussing 3 layers covering the brain...welcome the 4th! Which might pay a role in
aging, neurodegenerative dx & tumors. Brilliant 👏 study outlining it's function especially with #myeloids @NSTumorSection
https://t.co/C52BWZNfUW

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Excited to share our study based on a phase III multi-centered trial. Congrats ⁦@KristinHuntoon⁩ Association of Circulating Markers with Cognitive Decline After #Radiation for #BrainMetastasis #endcancer ⁦@MDAndersonNews⁩ https://t.co/KLpDRdtDCs

[EMPIRI @empiricancer]

Humbled and thrilled to present once again at the #TXLifeScienceForum by @ricealliance and @BioHouston. Aiming to repeat as “Most Promising Company” once again. https://t.co/ay9trTFSGc

[Thomas Gallup @tdgallup]

@corimargain_BME @empiricancer thanks Cori!!! :)

[EMPIRI @empiricancer]

Thank you Gulf Coast Consortia for a great event #GCCSCO22! It was great to meet everyone. Thank you all for stopping by to review and discuss our poster. We’re here in TMC, so please visit https://t.co/QWHOHyRT20 to see how we can help your research. #singlecell #EMPIRI

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

@ppisters @DrValeraeLewis @TexasBPWFoundat @WTereffeMD @LauraMComer @sgswisher @RannaParekh @ELTravisPhD @maryannesapon Humbled and honored to receive the Texas Business Award @TexasBPWFoundat today. Thank you @ppisters @ELTravisPhD @WTereffeMD @sgswisher @FrederickLangMD for your support #oncsurgery. Congrats @DrValeraeLewis @MDAndersonNews #BestPlaceToWork #surreal

[EMPIRI @empiricancer]

Emerging research shows how selecting the right drug for individual patients requires more than genomics. How might #functionalprecisionmedicine change our approach to cancer treatment? https://t.co/tuehnLFJ3K
#Precisiononcology #personalizedmedicine

[EMPIRI @empiricancer]

Determine personalized patient response to cancer therapies in 8 days or less, before treatment even starts. Our #tissueslice assay maintains the tumor microenvironment for accurate, individualized pre-treatment testing #oncology #personalizedmedicine https://t.co/SmX2rjcSnL

[Kristin Huntoon @KristinHuntoon]

First talk early this morning @CNS_Update Many thanks to the @NSTumorSection for letting me share our work importance of targeting protumorigeneic myeloid cells in #GBM @BettyKimLab @wenjiang_nano @Yunlab7 Also many thanks to @GarniBDarian for capturing the moment as well.

[EMPIRI @empiricancer]

scRNA-seq shows the #tumormicroenvironment plays an important role in treatment response. #EMPIRI offers our #tissueslice assay, which maintains the native microenvironment, to test patient tissues and select the most effective #cancertherapy in a clinically actionable timeframe

[UT MD Anderson @UTMDAnderson]

It may sound like science fiction, but nanomedicine could be used to improve cancer treatment.

Our Dr. Betty Kim explains how this approach targets tumor cells: https://t.co/G9LwcD2m1g @BettyKimLab #Nanomedicine #EndCancer

[EMPIRI @empiricancer]

Thrilled to receive a multi-PI #R01 grant from #NIH #NCI with Dr. Naoto Ueno (#MDAnderson) and Dr. Kyuson Yun (#HoustonMethodist). Funding will enable pre-clinical and clinical validation of E-slice to predict #TNBC patient response to treatments. #Breastcancer #Immunotherapy